Xenetic Biosciences, Inc.XBIONASDAQ
Loading
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.50% | -3.44% | +16.14% | -18.79% | +67.19% |
| Gross Profit Growth | +0.50% | -3.44% | +16.14% | -18.79% | +67.19% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +0.60% | +0.33% | +0.09% | +0.09% | +0.03% |
| Weighted Average Shares Diluted Growth | +0.60% | +0.33% | +0.09% | +0.09% | +0.03% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | -100.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -32.73% | -34.92% | -38.35% | -40.73% | -37.01% |
| Book Value per Share Growth | -35.78% | -38.87% | -41.02% | -40.28% | -43.79% |
| Debt Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| R&D Expense Growth | -63.94% | +6.83% | -6.91% | -29.69% | +105.57% |
| SG&A Expenses Growth | +1.15% | -25.87% | -21.35% | -41.79% | +9.32% |